Dirican, E. (2020). BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model. Asian Pacific Journal of Cancer Prevention, 21(1), 1-1. doi: 10.31557/APJCP.2020.21.1.1
MLA
Ebubekir Dirican. "BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model". Asian Pacific Journal of Cancer Prevention, 21, 1, 2020, 1-1. doi: 10.31557/APJCP.2020.21.1.1
HARVARD
Dirican, E. (2020). 'BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model', Asian Pacific Journal of Cancer Prevention, 21(1), pp. 1-1. doi: 10.31557/APJCP.2020.21.1.1
VANCOUVER
Dirican, E. BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model. Asian Pacific Journal of Cancer Prevention, 2020; 21(1): 1-1. doi: 10.31557/APJCP.2020.21.1.1